US 9453028
Protein kinase C inhibitors and uses thereof
granted A61KA61K31/5383A61P
Quick answer
US patent 9453028 (Protein kinase C inhibitors and uses thereof) held by Rigel Pharmaceuticals, Inc. expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/5383, A61P, A61P1/00, A61P1/04